Navigation Links
TransIT-siQUEST Transfection Reagent from Mirus Bio Corporation

ProductsTransIT-siQUEST Transfection Reagent from Mirus Bio Corporation
Company Mirus Bio Corporation
Item TransIT-siQUEST Transfection Reagent
Price $328.00
Description Cellular uptake of long double stranded RNA (dsRNA) has been shown to induce RNA interference in a diverse group of organisms as well as insect cells in culture. RNA interference leads to the inhibition of protein expression by utilizing sequence-specific, dsRNA-mediated destruction of the target messenger RNA (mRNA). Attempts to induce RNA interference using long dsRNA in mammalian cell lines have been met with limited success, due in part to the induction of the interferon response, which results in a general inhibition of protein synthesis. Recently, it has been shown that when short RNA duplexes are introduced into mammalian cells in culture, sequence-specific inhibition of target mRNA can be realized without introducing an interferon response. These short dsRNA, referred to as small interfering RNAs (siRNA), act catalytically at sub-molar ratios to cleave greater than 95% of the target mRNA in the cell. The RNA interference effect can be long-lasting and may be detectable after many cell divisions. These properties make siRNA extremely effective at inhibiting target gene expression.

Mirus Corporation, in recognition of these significant findings, has developed TransIT-siQUEST Transfection Reagent, which enables highly efficient siRNA transfection with significantly reduced levels of cell damage as compared to cationic-liposome based transfection reagents. Transfections are most effective when carried out in complete growth media, with no media change or serum addition required. TransIT-siQUEST Reagent efficiently delivers siRNA to a wide range of cell lines, promoting high levels of target gene expression knockdown. These unique features make the TransIT-siQUEST Transfection Reagent ideal for siRNA-mediated gene silencing studies. The TransIT-siQUEST Reagent is a complement to Mirus popular TransIT-TKO siRNA Transfection Reagent. Each unique formulation provides a distinct transfection profile for high efficiency, broad-spectrum siRNA delivery.

Info Mirus Bio CorporationMirus Bio Corporation
505 S. Rosa Rd.
Madison, WI 53719

Call Mirus Bio Corporation to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-438-6816
Customer Service: (888) 530-0801 or (608) 441-2852
Fax Number: (608) 441-2849
Web Site: http://www.mirusbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Label IT siRNA Tracker Fluorescein Kit with TransIT-siQUEST Reagent from Mirus Bio Corporation
2. Label IT siRNA Tracker CX Rhodamine Kit with TransIT-siQUEST Reagent from Mirus Bio Corporation
3. Label IT siRNA Tracker TM Rhodamine Kit with TransIT-siQUEST Reagent from Mirus Bio Corporation
4. Label IT siRNA Tracker Biotin Kit with TransIT-siQUEST Reagent from Mirus Bio Corporation
5. Label IT siRNA Tracker Cy3 Kit with TransIT-siQUEST Reagent from Mirus Bio Corporation
6. TransIT-siQUEST Transfection Reagent from Mirus Bio Corporation
7. GenomONE-Neo EX HVJ-E 4 vial(s) Transfection Reagents from Cosmo Bio Co., Ltd.
8. Label IT siRNA Tracker CX-Rhodamine Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
9. Label IT siRNA Tracker Intracellular Localization Kit with TransIT-TKO Transfection Reagent (Cy5 Labeling Kit) from Mirus Bio Corporation
10. Label IT siRNA Tracker Fluorescein Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
11. Label IT siRNA Tracker Biotin Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family
Raf-1 (C-12)-G
Profilin-1/2 (FL-140)
HES-1 [Hairy 1], Available Summer 2003
Biology Products:
(Date:5/16/2008)...s the genetic identity of human immunodeficiency v...nsmission, in unprecedented detail. , The findin...or an effective HIV/AIDS vaccine, said researchers... The UAB team found that among billions of HIV var...Earlier studies have shown that a bottleneck effec...
(Date:5/15/2008)...cs Business in First Quarter, WALL, N.J., May 15 ...nc. (OTC Bulletin Board: BKYI), a leader in wirele...fication solutions, today announced its,financial ...., 2008 First Quarter Consolidated Results, Tota... months ended,March 31, 2008 was $2.5 million repr...
(Date:5/15/2008)...to long-held assumptions, high-salt diets may not ...tors from the Albert Einstein College of Medicine ...on after examining dietary intake among a national... Einstein researchers actually observed a signific...disease (CVD) associated with lower sodium diets. ...
(Date:5/15/2008)...e National Laboratory has signed a memorandum of u...boratory (SRNL) to collaborate on nuclear energy a...upport of critical U.S. Energy Department (DOE) ne...The MOU allows Argonne to remain a leader in nucle...r said. "Argonne has the nation,s largest concentr...
Breaking Biology News(10 mins):HIV infection stems from few viruses 2BIO-key(R) Reports First Quarter 2008 Results 2BIO-key(R) Reports First Quarter 2008 Results 3New study casts further doubt on risk of death from higher salt intake 2Argonne-SRNL agreement supports critical DOE, national priorities 2Methodist Healthcare Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of 3A 11625 1Methodist Healthcare Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of 3A 11625 2Methodist Healthcare Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of 3A 11625 3Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 1Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 2Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 3Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 4Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 5Maxygen Reports Fourth Quarter and Year End 2007 Financial Results 3218 6Learning Disabilities May Presage Later Language Problems 11622 1Learning Disabilities May Presage Later Language Problems 11622 2Ingen Technologies Brings Oxyview 28R 29 to Asia Through Major Medical Distributor 11620 1Ingen Technologies Brings Oxyview 28R 29 to Asia Through Major Medical Distributor 11620 2Ingen Technologies Brings Oxyview 28R 29 to Asia Through Major Medical Distributor 11620 3
...ientists are one step closer to unraveling the com...ight. Working with mice -- whose appetites are con... -- they have identified a specific type of neuron...hese neurons, adult mice stop eating and undergo r...found that absence of these neurons only influence...
...ncerns over the privacy of patients could be hampe...the health effects of environmental pollution, acc... Journal of Biomedical Informatics . , Data made ...ing from cancer clusters to the risk of living nea...tered or aggregated in order to protect the identi...
...ough quick to caution about the many things that c...ible to contain a Southeast Asian outbreak of avia...e production of a vaccine. , Using a computer mode...an population, the scientists have shown how a com...tration of antivirals, quarantine and prevaccinati...
...ldfires in Alaska and Canada in 2004 emitted about...vities in the continental United States during the...e National Center for Atmospheric Research (NCAR)....ns of ground-level ozone across much of the Northe...he extent to which wildfires contribute to atmosph...
Other Biology News:An essential regulator of body weight revealed 2An essential regulator of body weight revealed 3An essential regulator of body weight revealed 4Software 'agents' could help unmask reality of disease clusters 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 3NCAR analysis shows widespread pollution from 2004 wildfires 2
(Date:5/16/2008)... The landscape of scientific,publications strategy...t of,transparency guidelines. Half of global publi...function, but publications leaders foresee a shift...on, according to a new,report released by Best Pra...ed such influential companies as,Pfizer, GlaxoSmit...
(Date:5/16/2008)...romatide and Novasep have,extended their partnersh...oligonucleotide synthesis technology. The resultin...s of biotechnology and pharmaceutical industries,f... gram to industrial,scale production of high quali... to combine Chromatide,s experience,in solid phase...
(Date:5/16/2008)...a--,China Pharma Holdings, ...hich develops, manufactures, and markets generic a...ounced today that it donated 2,million RMB (approx...g,antibiotics, anti- virus and anti-cold medicines...arthquake hit the southwestern province of Sichuan...
(Date:5/16/2008)...etrix Institute (, http://www.metametrixinstitute....ry Evaluations for Integrative and Functional Medi.... Lord and J. Alexander Bralley.,This book follows...ory,Evaluations in Molecular Medicine, published i...f Metametrix Inc., a leader in nutritional and,met...
Breaking Biology Technology:Industry Executives Finding Value in Shift of Scientific Publications 2Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 2Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 3Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 4China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief 2Introducing Laboratory Evaluations for Integrative and Functional Medicine 2
...increasing computerization of society. For example...e. But how about e-tickets for speeding or running...l vehicles have been progressively fitted with mor...uters connected over a radio-based IP solution. In...nd later on, officers can file them by computer an...
...ers will receive $250,000 in tax credits to build ... The tax credits were announced by Gov. Jim Doyle,...egional Economic Partnership (NEWREP) Technology Z...ider of sourced-based accounting systems. It will ...acility. The expansion is expected to create up to...
...f Mike Strand in Eau Claire and a finalist in Gove...as landed $250,000 from the Chippewa Valley Angel...ine Kiosks, has a plan to put video screens showin...ointments. After reaching the statewide business-p... category at Eau Claire Area Economic Development ...
...ract the presence of major pharmaceutical companie...own environment, said a panel assembled Monday nig...ces Association. , ,Part of building the future to...orporations, said WBMA President and EraGen CEO Ir...nt with Cushman and Wakefields Business Incentives...
Other Biology Technology:Wisconsin State Patrol goes high-tech with e-tickets 2Panel stresses drawing outside biotech firms to state 2